Brenus Pharma

Issoire, France

Brenus Pharma is an allogeneic platform to generate immune therapy ambitioning to harness patient immune system & prevent cancer resistance.

$25.0M raised

Sep 2024

Series A

Biotechnology Pharmaceutical

Top Investors

BpifranceUI InvestissementEurostarsMeusinvest (Noshaq)Crédit Agricole Centre-Est

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Brenus Pharma

How much funding has Brenus Pharma raised?

Brenus Pharma has raised $25.0M in total funding. The most recent round was Series A. The last funding was announced in September 2024.

Who are Brenus Pharma's investors?

Brenus Pharma's investors include Bpifrance, UI Investissement, Eurostars, Meusinvest (Noshaq), Crédit Agricole Centre-Est.

Where is Brenus Pharma headquartered?

Brenus Pharma is headquartered in Issoire, France.

What does Brenus Pharma do?

Brenus Pharma is an allogeneic platform to generate immune therapy ambitioning to harness patient immune system & prevent cancer resistance.

What stage is Brenus Pharma at?

Brenus Pharma is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated September 18, 2024.

MLA

"Brenus Pharma — Funding & Investors." VCBacked, September 18, 2024, https://www.vcbacked.co/company/brenus-pharma. Accessed June 7, 2026.

APA

VCBacked. (2024). Brenus Pharma — Funding & Investors. Retrieved June 7, 2026, from https://www.vcbacked.co/company/brenus-pharma

Wikipedia (cite web)

{{cite web |title=Brenus Pharma — Funding & Investors |url=https://www.vcbacked.co/company/brenus-pharma |website=VCBacked |access-date=June 7, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated September 18, 2024.

Similar Companies in Biotechnology